Browse Investors
(current)
Browse Companies
Contact Us
About Us
Login
Sign Up
Login
×
Please
Click Here
to resend email verification.
Enter Email
Enter Password
Forgot your password?
Login
Log in with
Log in with LinkedIn
Log in with Facebook
By logging in, I agree to the
Terms of Use.
New to LondCap?
Sign up
Andrew Weiss
Senior VP, Head Investor Relations and Corporate Communications
Idorsia Pharmaceuticals Ltd
Allschwil, Switzerland
Request Meeting / Call
Message
Home
Company Profile
Personal and Company Information
FIRST NAME
Last NAME
Job Title
Company Name
Country
City
Company url
Fundraising URL
Company Video
Slideshare URL
Company Profile
Company Tagline
Company Profile
Idorsia Ltd is a Switzerland-based biopharmaceutical company, which specializes in the discovery and development of small molecules, to meet significant unmet medical needs. The Company will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. The Company's development compounds target a number of different diseases such as: Resistant Hypertension, Systemic lupus erythematosus, Chronic insomnia and Fabry disease, among others.
Personal Biography
Company Details
Company Type
Public Company
Funding Type
Non-Deal Roadshow
Sector Type
Health Care
Industry
Biotechnology
Fundraising Details
Amount Raised $
Funding Goal $
Minimum Reservation $
Maximum Reservation $
% Equity
Open Date
Closing Date
Company Video
Social Media
LinkedIn URL
Facebook URL
Twitter URL
Share
Report
Report/Abuse
THANK YOU FOR YOUR INTEREST
×
$
Add Comments
Meet During Conference
Meet in Investors Office
Conference Call
Meet in Fundraiser Office
Submit
THANK YOU FOR YOUR INTEREST
×
Add Comments
Submit
Report user as abuse
×
Description
Report
